Ticker Scorecard - AXNX Basics Company: Axonics Modulation Technologies, Inc. IPO Date: October 29, 2018 Sector: Healthcare Industry: Medical Devices Activated in VL: False Average Daily Range Avg Daily Range: $0.94 | 2.10% Avg Daily Range (30 D): $0.47 | 0.67% Avg Daily Range (90 D): $0.13 | 0.18% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): M Avg Daily Volume (90 D): .25M Trade Size Avg Trade Size (Sh.): 67 Avg Trade Size (Sh.) (30 D): 261 Avg Trade Size (Sh.) (90 D): 92 Institutional Trades Total Inst.Trades: 3,811 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $3.68M Avg Inst. Trade (90 D): $2.2M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.25M Avg Closing Trade (30 D): $55.44M Avg Closing Trade (90 D): $3.53M Avg Closing Volume: 56.86K     News Sep 27, 2024 @ 7:45 PM Axonics Shares Fall Despite Australia's Approval f... Source: Zacks Mar 29, 2024 @ 4:00 PM All You Need to Know About Axonics (AXNX) Rating U... Source: Zacks Equity Research Mar 15, 2024 @ 12:53 PM Axonics (AXNX) Gets CE Mark for Sacral Neuromodula... Source: Zacks Equity Research Feb 29, 2024 @ 5:01 PM Beyond The Numbers: 7 Analysts Discuss Axonics Sto... Source: Benzinga Insights Feb 28, 2024 @ 10:40 PM Axonics Modulation Technologies (AXNX) Q4 Earnings... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $ $.14 $-.38 Diluted EPS $ $.13 $-.38 Revenue $ 116.19M $ 114.57M $ 91.41M Gross Profit $ 89.65M $ 89.14M $ 69.25M Net Income / Loss $ -.02M $ 6.9M $ -19.11M Operating Income / Loss $ -6.27M $ 3.68M $ -19.18M Cost of Revenue $ 26.54M $ 25.42M $ 22.16M Net Cash Flow $ 74.29M $ -61.22M $ 130.95M PE Ratio